Michelle Melisko

机构：University of California, San Francisco · ORCID：0000-0002-8729-4667

发表论文 339 篇 · 总被引 11442 次 · h-index 51

代表论文

• Immune Subtyping Identifies Patients With Hormone Receptor–Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial (2025 · JCO Precision Oncology · 被引 5)
• Multi-institutional analysis of incidence and risks for late-onset immune toxicity in breast cancer (2025 · npj Breast Cancer · 被引 3)
• Phase Ib study of intratumoral talimogene laherparepvec (T-VEC) in combination with chemotherapy or endocrine therapy in patients with advanced HER2-negative breast cancer (2025 · npj Breast Cancer · 被引 3)
• Tucatinib–trastuzumab–capecitabine for treatment of leptomeningeal metastasis in women with HER2+ breast cancer: TBCRC049 phase 2 study results (2026 · Nature Cancer · 被引 1)
• Evaluating survival trends over time in patients with metastatic breast cancer and brain metastases: a single center retrospective cohort study (2025 · Breast Cancer Research · 被引 1)
• Adaptive cohort design and LAT1 expression scale: study protocol for a Phase 2a trial of QBS72S in breast cancer brain metastases (2025 · BMC Cancer · 被引 1)